MSH|^~\&|MIC|SMH|||202002181014||ORU^R01|4169798|D|2.3|||AL|NE
PID|1||SM00040180|SM40149|MICTEST^DELIGHTED^||20100925|M||||||||||SM005007/18|9876490648
OBR|1|39471^MIC|00029779^20:MT0000076R^MIC^20:MT76^39471|700.2205^OP^Ova and parasites^^^673-4||202002181013|202002181013|||||||202002181013|Stool in SAF transport^^^|||||||||MB|F||||
OBX|1|ST|700.2200^OPBCCDC R^Ova and parasites BCCDC^^X500^^S:RAC|1|>BCCDC||||||F|||202002181014

MSH|^~\&|LAB|LMH|||202002181015||ORU^R01|4169799|D|2.3|||AL|NE
PID|1||LM00005528|LM5330|LUMEDTEST^TORONTO^||19880908|F||||||||||LM000762/19|9874745485
OBR|1|39470^LAB|00029778^1802:CU00002R^LAB^180220:CU2^39470|560.7970^UACR^Ur Alb Creat Ratio (ACR) Rand^^^32294-1||202002180905|202002181009|||||||202002181009||||||||||LAB|F||||
OBX|1|ST|561.0860^UACR R^U Albumin Creat Ratio Random^^32294-1^32294-1|1|11.1^^Y|mg/mmol|<2.0|H||A^S|F|||202002181015
NTE|1||Grossly elevated urine albumin result. Consider use of total
NTE|2||urine proteins for clinically appropriate patient. For
NTE|3||further information contact Dr Arun Garg at
NTE|4||arun.garg@fraserhealth.ca
NTE|5||NOTE: Ur ALB:CR Ratio Reference target based on
NTE|6||      CDA Guidelines for Diabetic Care